V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20209352 | 20078031 | 1.93 | 100.9 | 03 | 2016-06-08 | 2016-06-22 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100573194 |
| 20209354 | 20078032 | 1.75 | null | null | 2017-09-11 | 2017-09-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101039501 |
| 20209358 | 20078033 | 1.81 | 74 | Palliative (P) | 2017-07-12 | 2017-10-23 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101556680 |
| 20209359 | 20078034 | 1.49 | 76.6 | Curative (C) | 2016-02-06 | 2016-02-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101010607 |
| 20209360 | 20078035 | 0 | 0 | Palliative (P) | 2019-05-07 | 2019-05-21 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101501844 |
| 20209362 | 20078036 | 1.78 | 56 | Neo-adjuvant (N) | 2019-02-03 | 2019-02-03 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100954237 |
| 20209364 | 20078037 | 1.55 | 79.5 | Palliative (P) | 2018-01-21 | 2018-02-06 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101810159 |
| 20209367 | 20078038 | 1.65 | 96 | Curative (C) | 2017-11-28 | 2017-12-12 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100940637 |
| 20209377 | 20078039 | 1.74 | 112.6 | Palliative (P) | 2018-04-09 | 2018-04-13 | CAPECITABINE + CARBOPLATIN | N | null | CAPECITABINE + CARBOPLATIN | 100018237 |
| 20209383 | 20078040 | 1.54 | 66.9 | Curative (C) | 2018-01-14 | 2018-01-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100091764 |
| 20209385 | 20078041 | 1.73 | 73 | Neo-adjuvant (N) | 2016-06-18 | 2016-06-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100781244 |
| 20209390 | 20078042 | 1.68 | 100.9 | Curative (C) | 2016-05-27 | 2016-06-10 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101237858 |
| 20209396 | 20078043 | 1.74 | 108.1 | Neo-adjuvant (N) | 2018-02-22 | 2018-03-06 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101695725 |
| 20209397 | 20078044 | 1.79 | 72.5 | Curative (C) | 2017-04-14 | 2017-05-06 | CISPLATIN + FLUOROURACIL + RT | N | N | CISPLATIN + FLUOROURACIL | 100144430 |
| 20209398 | 20078045 | 1.49 | 78 | null | 2016-04-16 | 2016-04-16 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101289088 |
| 20209402 | 20078046 | 1.68 | 78.9 | Curative (C) | 2021-05-21 | 2021-05-21 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 101356115 |
| 20209406 | 20078047 | 1.81 | 83.4 | Curative (C) | 2019-03-30 | 2019-04-05 | Capecitabine + Carboplatin + RT | 02 | Y | DOXORUBICIN EMBOLISATION | 101355947 |
| 20209410 | 20078048 | 1.75 | 67.55 | Palliative (P) | 2019-08-04 | 2019-09-01 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101257540 |
| 20209411 | 20078049 | null | 64.9 | Curative (C) | 2020-11-24 | 2020-12-26 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100596236 |
| 20209412 | 20078050 | null | null | Neo-adjuvant (N) | null | 2019-07-08 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100635902 |
| 20209415 | 20078051 | 0 | 0 | Neo-adjuvant (N) | 2017-04-09 | 2017-04-22 | CAPECITABINE + CARBOPLATIN | 02 | null | DOXORUBICIN EMBOLISATION | 100500024 |
| 20209417 | 20078052 | 1.7 | 56.4 | Neo-adjuvant (N) | null | 2016-11-18 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100041293 |
| 20209421 | 20078053 | 1.87 | 118.8 | Curative (C) | 2016-04-30 | 2016-05-02 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101697938 |
| 20209423 | 20078054 | 1.62 | 50.1 | null | 2018-09-10 | 2018-09-10 | Capecitabine (21days) + Carboplatin | 02 | null | TRIAL UNSPECIFIED | 100681824 |
| 20209426 | 20078055 | 0 | 0 | Palliative (P) | 2018-05-01 | 2018-05-14 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100504565 |
| 20209427 | 20078056 | 1.81 | 63.6 | Palliative (P) | 2017-12-18 | 2017-12-18 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 100730740 |
| 20209428 | 20078057 | 1.71 | 111.1 | Palliative (P) | 2019-06-26 | 2019-06-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101518495 |
| 20209429 | 20078058 | 1.6 | 75.2 | Palliative (P) | 2017-08-01 | 2017-08-21 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101478603 |
| 20209436 | 20078059 | 0 | 0 | 03 | 2019-08-31 | 2019-09-25 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 100383197 |
| 20209441 | 20078060 | 1.71 | 56.3 | Curative (C) | 2016-08-28 | 2016-08-28 | Capecitabine (21days) + Carboplatin | 02 | Y | TRIAL UNSPECIFIED | 101255709 |
| 20209442 | 20078061 | 1.5 | 58.6 | Palliative (P) | 2018-07-30 | 2018-08-01 | Capecitabine + Carboplatin + RT | 02 | N | CAPECITABINE + CARBOPLATIN | 101354605 |
| 20209447 | 20078062 | 1.66 | 107.9 | null | 2017-04-12 | 2017-04-12 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101688873 |
| 20209450 | 20078063 | 1.61 | 85 | Palliative (P) | null | 2019-09-25 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101459495 |
| 20209452 | 20078064 | 1.55 | 70.6 | Neo-adjuvant (N) | 2019-12-13 | 2019-12-17 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101403780 |
| 20209458 | 20078065 | null | 65.4 | Curative (C) | 2019-08-24 | 2019-08-25 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101664351 |
| 20209459 | 20078066 | 1.8 | 68.5 | Palliative (P) | 2018-04-10 | 2018-05-01 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100111348 |
| 20209467 | 20078067 | 1.71 | 62 | Palliative (P) | 2017-01-23 | 2017-02-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101338543 |
| 20209473 | 20078068 | 1.64 | 117.3 | null | 2017-05-23 | 2017-05-25 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100036114 |
| 20209475 | 20078069 | 1.79 | null | Neo-adjuvant (N) | 2017-06-13 | 2017-06-14 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100518533 |
| 20209481 | 20078070 | 1.48 | 65.45 | Palliative (P) | 2017-04-26 | 2017-04-28 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100354214 |
| 20209482 | 20078071 | 1.73 | 67.6 | Neo-adjuvant (N) | 2017-11-24 | 2017-11-24 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101234439 |
| 20209485 | 20078072 | 1.67 | 77.2 | Neo-adjuvant (N) | 2020-02-09 | 2020-02-28 | Capecitabine (21days) + Carboplatin | N | null | CAPECITABINE + CARBOPLATIN | 100519344 |
| 20209486 | 20078073 | 1.69 | 95 | Neo-adjuvant (N) | 2020-01-25 | 2020-01-25 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100171174 |
| 20209487 | 20078074 | 1.77 | 46.9 | Curative (C) | 2021-12-31 | 2022-01-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101034084 |
| 20209489 | 20078075 | 0 | 0 | null | 2018-09-28 | 2018-10-12 | Doxorubicin chemoembolisation | 99 | null | DOXORUBICIN EMBOLISATION | 101673542 |
| 20209490 | 20078076 | 1.72 | 55.1 | Curative (C) | 2019-08-28 | 2019-09-05 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100385181 |
| 20209491 | 20078077 | 1.72 | 59.1 | Palliative (P) | 2016-02-06 | 2016-02-21 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100823261 |
| 20209494 | 20078078 | 1.72 | 62.8 | Palliative (P) | 2016-10-12 | 2016-10-19 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101656465 |
| 20209495 | 20078079 | 1.7 | 84 | Palliative (P) | 2018-09-12 | 2018-10-24 | Capecitabine + Carboplatin + RT | N | N | TRIAL UNSPECIFIED | 100602498 |
| 20209497 | 20078080 | 1.66 | 68.3 | null | 2018-09-21 | 2018-09-27 | Cisplatin +Fluorouracil (3 wk) | N | null | CISPLATIN + FLUOROURACIL | 100982992 |